PRELAJ, ARSELA

PRELAJ, ARSELA  

DIPARTIMENTO DI ELETTRONICA, INFORMAZIONE E BIOINGEGNERIA  

Mostra records
Risultati 1 - 20 di 54 (tempo di esecuzione: 0.027 secondi).
Titolo Data di pubblicazione Autori File
A Contrastive Variational AutoEncoder for NSCLC Survival Prediction with Missing Modalities 1-gen-2025 Miskovic, VanjaTrovo, FrancescoPedrocchi, Alessandra Laura GiuliaPrelaj, Arsela +
Abstract PO-065: Artificial intelligence to improve selection for NSCLC patients treated with immunotherapy 1-gen-2021 Prelaj, ArselaRestelli, MarcelloPedrocchi, AlessandraTrovo, Francesco +
Aiding data retrieval in clinical trials with large language models: The APOLLO 11 Consortium in advanced lung cancer patients 1-gen-2025 Corso, FedericaMazzeo, LauraMiskovic, VanjaFerrarin, AlbertoPedrocchi, AlessandraPrelaj, Arsela +
ALK/ROS1 rearrangements: A real hallmark for thromboembolic events in cancer patients? 1-gen-2020 Prelaj A. +
An ensemble approach to predict immunotherapy efficacy in non-small cell lung cancer using digital pathology 1-gen-2025 A. ZecMarcello Matteo DeclichMatteo SaccoF. Trovo'A. PrelajVanja Miskovic +
APOLLO 11 Project, Consortium in Advanced Lung Cancer Patients Treated With Innovative Therapies: Integration of Real-World Data and Translational Research 1-gen-2023 Prelaj, ArselaProvenzano, LeonardoMazzeo, LauraTrovò, FrancescoManglaviti, SaraAmbrosini, PaoloPedrocchi, Alessandra Laura GiuliaMiskovic, Vanja +
APOLLO11: a bio-data-driven model for clinical and translational research in lung cancer 1-gen-2026 Prelaj, ArselaProvenzano, LeonardoMiskovic, VanjaMazzeo, LauraFavali, MargheritaZec, AleksandraFerrarin, AlbertoDi Mauro, Rosa MariaCatania, ChiaraCorso, FedericaScoazec, GiovanniPedrocchi, AlessandraGenova, CarloGuirges, BeshoyLicciardello, Cristina +
Artificial intelligence for predictive biomarker discovery in immuno-oncology: a systematic review 1-gen-2024 Prelaj, A.Miskovic, V.Trovo, F.Mazzeo, L.Provenzano, L.Favali, M.Ambrosini, E.Pedrocchi, A. L. G. +
Automatic Cough Analysis for Non-Small Cell Lung Cancer Detection 1-gen-2025 Giangregorio C.Licciardello C. M.Miskovic V.Provenzano L.Prelaj A.Ambrosini E.Ferrante S. +
Beyond first-line immunotherapy: Potential therapeutic strategies based on different pattern progressions: Oligo and systemic progression 1-gen-2021 Prelaj A. +
Carcinomatosis under control by osimertinib in EGFR and TP53 mutated lung adenocarcinoma 1-gen-2021 Prelaj, Arsela +
Case Report: Exceptional Response to Poziotinib in Patient with Metastatic Non-Small Cell Lung Cancer With EGFR Exon 20 Insertion Mutation 1-gen-2022 Prelaj, ArselaManglaviti, Sara +
Cell-free DNA from cerebrospinal fluid can be used to detect the EGFR mutation status of lung adenocarcinoma patients with central nervous system metastasis 1-gen-2021 Prelaj A. +
Characteristics and impact of real-world evidence studies in oncology: comprehensive mapping review of publications evaluating targeted therapies in solid tumours 1-gen-2024 A. PrelajV. MiskovicL. Provenzano +
Characterization of patients with metastatic non-small-cell lung cancer obtaining long-term benefit from immunotherapy 1-gen-2019 Prelaj A. +
Choosing wisely first line immunotherapy in non-small cell lung cancer (NSCLC): what to add and what to leave out 1-gen-2019 Prelaj A. +
Circulating Fatty Acid Profile as a Biomarker for Immunotherapy in Advanced Non-Small Cell Lung Cancer 1-gen-2022 Prelaj, Arsela +
Cost-effectiveness models of non–small cell lung cancer: A systematic literature review 1-gen-2025 Prelaj, Arsela +
Cost-effectiveness of first-line osimertinib informed by electronic medical records via text-mining: a real-world Italian case study of EGFR-mutated advanced NSCLC patients 1-gen-2025 Corso, F.Scotti, F.Mazzeo, L.Torri, V.Cappozzo, A.Paganoni, A. M.Prelaj, A.Ieva, F. +
Data analytics for real-world data integration in TKI-treated NSCLC patients using electronic health records 1-gen-2025 Scotti, F.Torri, V.Mišković, V.Giani, C.Paganoni, A. M.Ieva, F.Prelaj, A. +